ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,606,896 | +186.6% | 125,091 | +229.4% | 0.01% | +400.0% |
| Q2 2023 | $909,621 | -45.7% | 37,980 | -57.3% | 0.00% | -66.7% |
| Q1 2023 | $1,675,149 | +1026.7% | 89,009 | +853.1% | 0.00% | – |
| Q4 2022 | $148,676 | -23.0% | 9,339 | -21.2% | 0.00% | – |
| Q3 2022 | $193,000 | +16.3% | 11,852 | +0.5% | 0.00% | – |
| Q2 2022 | $166,000 | -89.0% | 11,794 | -81.1% | 0.00% | -100.0% |
| Q1 2022 | $1,507,000 | +9.7% | 62,260 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $1,374,000 | – | 58,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |